Literature DB >> 31250386

Obesity in Patients with Endometrial Cancer: May It Affect the Surgical Outcomes of Laparoscopic Approach?

Z M Gambacorti-Passerini1, C López-De la Manzanara Cano2,3, C Pérez Parra2,4, M C Cespedes Casas2, L Sánchez Hipólito2, C Martín Francisco2, J R Muñoz-Rodríguez5.   

Abstract

OBJECTIVE: To evaluate the impact of obesity on surgical outcomes for women with endometrial cancer (EC) managed by laparoscopic surgery. Minimal invasive surgery has been incorporated in the surgical management of EC, improving perioperative outcomes. However, this approach may become more challenging in case of obesity. So it is important to accurately evaluate and establish the most appropriate surgical approach for these patients.
MATERIALS AND METHODS: From January 2008 through April 2016, we conducted a prospective observational study, including all consecutive patients with a histological diagnosis of EC undergoing surgical staging by laparoscopy at our institution. Patients were classified in two groups (obese vs non-obese) according to their body mass index. Information about short- and long-term outcomes were recorded and analyzed during an outpatient follow-up.
RESULTS: Between January 2008 and April 2016, 83 women underwent laparoscopic surgery for EC at our institution. Forty-six (56.6%) of them were classified as obese. Surgical outcomes were similar in both groups. No significant difference was reported in surgical time, number of lymph nodes removed, blood loss, length of hospital stay, and incidence of intra- or postoperative complications. Also, long-term outcomes did not show any statistical significant difference: recurrence rate was 6.4% (3/47) among obese patients and 13.9% (5/36) among non-obese (p = 0.251). No difference was reported even in time to recurrence (log-rank p = 0.280) and in survival time (log-tank p = 0.132) between the two groups.
CONCLUSIONS: Our results show that obesity did not impair the outcomes of laparoscopic surgery for EC. This surgical approach may be offered to obese patients with the same level of safety, radicality, and efficiency as for the normal-weight population.

Entities:  

Keywords:  Endometrial cancer; Laparoscopy; Obesity; Surgical approach

Mesh:

Year:  2019        PMID: 31250386     DOI: 10.1007/s11695-019-03986-2

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  25 in total

1.  The impact of obesity and age on quality of life in gynecologic surgery.

Authors:  Vivian E von Gruenigen; Karen M Gil; Heidi E Frasure; Eric L Jenison; Michael P Hopkins
Journal:  Am J Obstet Gynecol       Date:  2005-10       Impact factor: 8.661

2.  Total laparoscopic hysterectomy for uterine pathology: impact of body mass index on outcomes.

Authors:  Katherine A O'Hanlan; Suzanne L Dibble; Deidre T Fisher
Journal:  Gynecol Oncol       Date:  2006-07-10       Impact factor: 5.482

3.  Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study.

Authors:  Joan L Walker; Marion R Piedmonte; Nick M Spirtos; Scott M Eisenkop; John B Schlaerth; Robert S Mannel; Richard Barakat; Michael L Pearl; Sudarshan K Sharma
Journal:  J Clin Oncol       Date:  2012-01-30       Impact factor: 44.544

4.  Obesity is a predictor of morbidity in 1,629 patients who underwent adrenalectomy.

Authors:  Hadiza S Kazaure; Sanziana A Roman; Julie A Sosa
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

5.  Impact of Obesity on Surgical Treatment for Endometrial Cancer: A Multicenter Study Comparing Laparoscopy vs Open Surgery, with Propensity-Matched Analysis.

Authors:  Stefano Uccella; Matteo Bonzini; Stefano Palomba; Francesco Fanfani; Marcello Ceccaroni; Renato Seracchioli; Enrico Vizza; Annamaria Ferrero; Giovanni Roviglione; Paolo Casadio; Giacomo Corrado; Giovanni Scambia; Fabio Ghezzi
Journal:  J Minim Invasive Gynecol       Date:  2015-08-14       Impact factor: 4.137

6.  Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation.

Authors:  Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Camilo Silva; Fernando Rotellar; María J Gil; Javier A Cienfuegos; Javier Salvador; Gema Frühbeck
Journal:  Clin Endocrinol (Oxf)       Date:  2007-09-04       Impact factor: 3.478

7.  Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass.

Authors:  Javier Gómez-Ambrosi; Javier Salvador; Fernando Rotellar; Camilo Silva; Victoria Catalán; Amaia Rodríguez; M Jesús Gil; Gema Frühbeck
Journal:  Obes Surg       Date:  2006-03       Impact factor: 4.129

Review 8.  Laparoscopic treatment for endometrial cancer: a meta-analysis of randomized controlled trials (RCTs).

Authors:  Stefano Palomba; Angela Falbo; Rita Mocciaro; Tiziana Russo; Fulvio Zullo
Journal:  Gynecol Oncol       Date:  2008-10-29       Impact factor: 5.482

9.  Assessment of the effects of severe obesity and lifestyle risk factors on stage of endometrial cancer.

Authors:  Marisa A Bittoni; James L Fisher; Jeffrey M Fowler; George L Maxwell; Electra D Paskett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11-01       Impact factor: 4.254

10.  Laparoscopic surgery for endometrial cancer: increasing body mass index does not impact postoperative complications.

Authors:  C William Helm; Cibi Arumugam; Mary E Gordinier; Daniel S Metzinger; Jianmin Pan; Shesh N Rai
Journal:  J Gynecol Oncol       Date:  2011-09-28       Impact factor: 4.401

View more
  2 in total

1.  Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study.

Authors:  Khaled Gaballa; Islam H Metwally; Basel Refky; Shadi Awny; Mohamed Abdelkhalek; Mohamed Hamdy
Journal:  Indian J Surg Oncol       Date:  2022-01-17

2.  Impact of Obesity on Clinical and Financial Outcomes of Minimally Invasive Hysterectomy for Benign Conditions.

Authors:  Margot Le Neveu; Abdelrahman AlAshqar; Jaden Kohn; Anastasia Tambovtseva; Karen C Wang; Mostafa A Borahay
Journal:  J Obstet Gynaecol Can       Date:  2022-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.